Wed, 05 Feb 2014 17:48:00 GMT ~ Cannabis Science (CBIS) Collaborates with Patients Out of Time, Inc., a Global Patient Advocacy Organization Dedicated to Educating Health Professionals and the Public about Therapeutic Cannabis [PR Newswire] - COLORADO SPRINGS, Colo., Feb. 5, 2014 /PRNewswire/ -- (NASD OTC: CBIS) Cannabis Science, Inc., a U.S. Company specializing in cannabis-based pharmaceutical development and related consulting operations, provides development consultation and financial support to Patients Out of Time, Inc., the premiere non-profit organization devoted to helping educate the public and healthcare professionals about the safety and effectiveness of medical cannabis. Cannabis Science is pleased to facilitate the critical work of this unique non-profit organization's ongoing conferences, events, workshops and global distribution of leading edge educational content and online resources. CBIS's support includes supporting Patients Out of Time's marquee conference in Portland, Oregon in May 2014, entitled "The Eighth National Clinical Conference on Cannabis Therapeutics", and future conferences, helping to expand the organization's conferences from biennial to annual, for which participants or learners may earn ACCME (fully recognized continuing education) credits. read full: http://finance.yahoo.com/news/cannabis-science-cbis-collaborates-patients-174800369.html *********************************************************
Tue, 04 Feb 2014 13:52:00 GMT ~ Cannabis Science (CBIS) Applauds U.S. Congress on Moving to Legalize Hemp Cultivation and Research; Calls Today for Final Senate Passage of Farm Bill and President's Signature into Law [PR Newswire] - COLORADO SPRINGS, Colo., Feb. 4, 2014 /PRNewswire/ -- Cannabis Science, Inc. (CBIS), a U.S. Company specializing in cannabis-based pharmaceutical development and related consulting operations, is pleased that the U.S. Congress and President Obama appear positioned to approve the first federal law to legalize hemp cultivation and advanced research on a federal level, creating unprecedented opportunities for the Company to pursue patient-based pharmaceutical solutions for patients. Last week the U.S. House of Representatives approved the "farm bill" that contains a provision for certain cultivation of industrial hemp for research in a number of U.S. states. The Senate is expected to approve the measure as soon as today, and President Obama has declared that he will sign the bill into law, changing the legal landscape for the entire hemp industry. "As hemp and cannabis both come from the same plant, federal movement on liberalization of hemp cultivation and research will positively impact Cannabis Science's opportunities for pharmaceutical research and development of cannabis and cannabinoid-based pharmaceutical products for patients. The House has approved the bill, and the Senate is expected vote in favor of it today or tomorrow, with near certain approval from the President. The Company is formulating its strategy for this regulatory opening to more quickly bring pharmaceutical products to market for the benefit of patients in need," said Chad S. Johnson, Chief Operating Officer and General Counsel of Endocan Corporation. read full: http://finance.yahoo.com/news/cannabis-science-cbis-applauds-u-135200205.html *********************************************************
Mon, 03 Feb 2014 13:26:00 GMT ~ CBIS Provides Growth Guidance on its Medicine Dispensing Systems (MDS) Exclusive & Non-Exclusive Agreements [PR Newswire] - COLORADO SPRINGS, Colo., Feb. 3, 2014 /PRNewswire/ -- (NASDAQ OTC: CBIS) Cannabis Science, Inc., a U.S. Company specializing in cannabis-based pharmaceutical development and related consulting operations, provides ... read full: http://finance.yahoo.com/news/cbis-provides-growth-guidance-medicine-132600614.html *********************************************************
Wed, 29 Jan 2014 17:55:00 GMT ~ Cannabis Science (CBIS) Government Affairs Representative Lobbys' with the U.S. House of Representatives' Cannabis Caucus for President Obama to Join Congressional Cannabis Caucus in Ending Federal Restrictions on Cannabinoid Research [PR Newswire] - COLORADO SPRINGS, Colo., Jan. 29, 2014 /PRNewswire/ -- (NASDAQ OTC: CBIS) After President Obama's State of the Union Address this week, Cannabis Science is leading the private sector effort to take cannabis-derived drugs to market. The company's government relations team lead, Rick Blake, is working with the U.S. House of Representatives' Cannabis Caucus to ensure that the President signs an Executive Order to decriminalize cannabis research. This is one of the bipartisan initiatives of the Members of the Cannabis Caucus being facilitated by Cannabis Science. In contrast to many other countries, the regulatory landscape of the United States creates unreasonable restrictions on the ability of scientists and physicians to explore promising patient-driven research involving cannabis and cannabinoids. "Thousands of patients are awaiting the President's action to set cannabis research free," said Dorothy Bray, Ph.D., Director and CEO of Cannabis Science, Inc., one of the leading supporters of scientific cannabis drug development in the private sector. We applaud those congressional members in Colorado, California, Oregon, New York, Massachusetts and many other jurisdictions in the United States who have determined to take forward U.S. cannabis drug research." Dr. Bray and others on the CBIS team support critical legislation for the use of cannabis in the treatment of multiple illnesses including cancer. read full: http://finance.yahoo.com/news/cannabis-science-cbis-government-affairs-175500858.html *********************************************************
Tue, 28 Jan 2014 18:53:00 GMT ~ Greta Gaines Former Member of the National Board of the National Organization to Reform Marijuana Law (NORML) Joins Cannabis Science (CBIS) Team to Enhance Company's Business Development Activities [PR Newswire] - COLORADO SPRINGS, Colo., Jan. 28, 2014 /PRNewswire/ -- (NASDAQ OTC: CBIS) Cannabis Science, Inc., a U.S. Company specializing in cannabis-based pharmaceutical development and related consulting operations, appoints the well known entertainer, Greta Gaines, to coordinate promotional activities and events. Greta Gaines was voted one of the 'TOP 100 Most Influential People in Cannabis' and is a former member of the National Board of the National Organization to Reform Marijuana Law (NORML). Greta Gaines has a sound knowledge of the cannabis industry and her international network provide a unique and valuable resource to the Company's promotion activities, including special events planned during the annual shareholder meetings in 2014 and 2015. read full: http://finance.yahoo.com/news/greta-gaines-former-member-national-185300387.html *********************************************************
##### chart ~ source: stockcharts.com
##### chart ~ source: eoddata.com
##### company info ~ source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/CBIS/company-info Ticker: $CBIS OTC Market Place: OTCQB CIK code: 0001024626 Company name: Cannabis Science, Inc. Company website: http://www.cannabisscience.com Incorporated In: NV, USA
News 
Market Data 
Discover 
